Is it time to move on to the next generation of clinical trials in older patients with cancer?

Lancet Healthy Longev. 2021 Dec;2(12):e774-e775. doi: 10.1016/S2666-7568(21)00279-8.

Authors

Hannah Lowe¹, Alastair Greystoke²

Affiliations

¹ Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals Foundation NHS Trust, Newcastle upon Tyne, UK.
² Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals Foundation NHS Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK. Electronic address: alastair.greystoke@newcastle.ac.uk.

PMID: 36098034
DOI: 10.1016/S2666-7568(21)00279-8

No abstract available

Publication types

Comment

MeSH terms

Aged
Aging
Humans
Neoplasms* / therapy